ラノラジンの世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE3983)
◆英語タイトル:Global Ranolazine Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE3983
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:88
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、ラノラジンの世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(500mg錠、1000mg錠)、用途別市場規模(病院、ドラッグストア)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・ラノラジンの市場動向
・企業の競争状況、市場シェア
・ラノラジンの種類別市場規模(500mg錠、1000mg錠)
・ラノラジンの用途別市場規模(病院、ドラッグストア)
・ラノラジンの北米市場規模2016-2027(アメリカ、カナダ)
・ラノラジンの欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・ラノラジンのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・ラノラジンの中南米市場規模2016-2027(メキシコ、ブラジル)
・ラノラジンの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Gilead Sciences、Lupin、Teva、Ajanta Pharma)
・結論
【レポートの概要】

Ranolazine, sold under the trade name Ranexa by Gilead Sciences, is a drug to treat angina that was first approved in 2006.

Market Analysis and Insights: Global Ranolazine Market
The global Ranolazine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ranolazine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ranolazine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ranolazine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ranolazine market.

Global Ranolazine Scope and Market Size
Ranolazine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ranolazine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
500 mg Tablet
1000 mg Tablet

Segment by Application
Hospital
Drug store

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Gilead Sciences
Lupin
Teva
Ajanta Pharma

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ranolazine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 500 mg Tablet
1.2.3 1000 mg Tablet
1.3 Market by Application
1.3.1 Global Ranolazine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Drug store
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Ranolazine Market Perspective (2016-2027)
2.2 Ranolazine Growth Trends by Regions
2.2.1 Ranolazine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Ranolazine Historic Market Share by Regions (2016-2021)
2.2.3 Ranolazine Forecasted Market Size by Regions (2022-2027)
2.3 Ranolazine Industry Dynamic
2.3.1 Ranolazine Market Trends
2.3.2 Ranolazine Market Drivers
2.3.3 Ranolazine Market Challenges
2.3.4 Ranolazine Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Ranolazine Players by Revenue
3.1.1 Global Top Ranolazine Players by Revenue (2016-2021)
3.1.2 Global Ranolazine Revenue Market Share by Players (2016-2021)
3.2 Global Ranolazine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ranolazine Revenue
3.4 Global Ranolazine Market Concentration Ratio
3.4.1 Global Ranolazine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ranolazine Revenue in 2020
3.5 Ranolazine Key Players Head office and Area Served
3.6 Key Players Ranolazine Product Solution and Service
3.7 Date of Enter into Ranolazine Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Ranolazine Breakdown Data by Type
4.1 Global Ranolazine Historic Market Size by Type (2016-2021)
4.2 Global Ranolazine Forecasted Market Size by Type (2022-2027)

5 Ranolazine Breakdown Data by Application
5.1 Global Ranolazine Historic Market Size by Application (2016-2021)
5.2 Global Ranolazine Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Ranolazine Market Size (2016-2027)
6.2 North America Ranolazine Market Size by Type
6.2.1 North America Ranolazine Market Size by Type (2016-2021)
6.2.2 North America Ranolazine Market Size by Type (2022-2027)
6.2.3 North America Ranolazine Market Size by Type (2016-2027)
6.3 North America Ranolazine Market Size by Application
6.3.1 North America Ranolazine Market Size by Application (2016-2021)
6.3.2 North America Ranolazine Market Size by Application (2022-2027)
6.3.3 North America Ranolazine Market Size by Application (2016-2027)
6.4 North America Ranolazine Market Size by Country
6.4.1 North America Ranolazine Market Size by Country (2016-2021)
6.4.2 North America Ranolazine Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Ranolazine Market Size (2016-2027)
7.2 Europe Ranolazine Market Size by Type
7.2.1 Europe Ranolazine Market Size by Type (2016-2021)
7.2.2 Europe Ranolazine Market Size by Type (2022-2027)
7.2.3 Europe Ranolazine Market Size by Type (2016-2027)
7.3 Europe Ranolazine Market Size by Application
7.3.1 Europe Ranolazine Market Size by Application (2016-2021)
7.3.2 Europe Ranolazine Market Size by Application (2022-2027)
7.3.3 Europe Ranolazine Market Size by Application (2016-2027)
7.4 Europe Ranolazine Market Size by Country
7.4.1 Europe Ranolazine Market Size by Country (2016-2021)
7.4.2 Europe Ranolazine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Ranolazine Market Size (2016-2027)
8.2 Asia-Pacific Ranolazine Market Size by Type
8.2.1 Asia-Pacific Ranolazine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Ranolazine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Ranolazine Market Size by Type (2016-2027)
8.3 Asia-Pacific Ranolazine Market Size by Application
8.3.1 Asia-Pacific Ranolazine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Ranolazine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Ranolazine Market Size by Application (2016-2027)
8.4 Asia-Pacific Ranolazine Market Size by Region
8.4.1 Asia-Pacific Ranolazine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Ranolazine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Ranolazine Market Size (2016-2027)
9.2 Latin America Ranolazine Market Size by Type
9.2.1 Latin America Ranolazine Market Size by Type (2016-2021)
9.2.2 Latin America Ranolazine Market Size by Type (2022-2027)
9.2.3 Latin America Ranolazine Market Size by Type (2016-2027)
9.3 Latin America Ranolazine Market Size by Application
9.3.1 Latin America Ranolazine Market Size by Application (2016-2021)
9.3.2 Latin America Ranolazine Market Size by Application (2022-2027)
9.3.3 Latin America Ranolazine Market Size by Application (2016-2027)
9.4 Latin America Ranolazine Market Size by Country
9.4.1 Latin America Ranolazine Market Size by Country (2016-2021)
9.4.2 Latin America Ranolazine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Ranolazine Market Size (2016-2027)
10.2 Middle East & Africa Ranolazine Market Size by Type
10.2.1 Middle East & Africa Ranolazine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Ranolazine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Ranolazine Market Size by Type (2016-2027)
10.3 Middle East & Africa Ranolazine Market Size by Application
10.3.1 Middle East & Africa Ranolazine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Ranolazine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Ranolazine Market Size by Application (2016-2027)
10.4 Middle East & Africa Ranolazine Market Size by Country
10.4.1 Middle East & Africa Ranolazine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Ranolazine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Details
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences Ranolazine Introduction
11.1.4 Gilead Sciences Revenue in Ranolazine Business (2016-2021)
11.1.5 Gilead Sciences Recent Development
11.2 Lupin
11.2.1 Lupin Company Details
11.2.2 Lupin Business Overview
11.2.3 Lupin Ranolazine Introduction
11.2.4 Lupin Revenue in Ranolazine Business (2016-2021)
11.2.5 Lupin Recent Development
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Teva Business Overview
11.3.3 Teva Ranolazine Introduction
11.3.4 Teva Revenue in Ranolazine Business (2016-2021)
11.3.5 Teva Recent Development
11.4 Ajanta Pharma
11.4.1 Ajanta Pharma Company Details
11.4.2 Ajanta Pharma Business Overview
11.4.3 Ajanta Pharma Ranolazine Introduction
11.4.4 Ajanta Pharma Revenue in Ranolazine Business (2016-2021)
11.4.5 Ajanta Pharma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ ラノラジンの世界市場規模・現状・予測2021年-2027年(Global Ranolazine Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。